GlassScriptPhysician profile
Sergio L Balingit, JR.
NPI 1669405312
$12,932.48
in general payments reported to CMS, 2019-2025
32 companies · $2,313 in 2025
The $2,313 reported for 2025 was more than what 89% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $436 · 2021: $686 · 2022: $1,257 · 2023: $5,000 · 2024: $2,440 · 2025: $2,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,685 · Education: $3,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,685.09 |
| Education | $3,067.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,178.47 | 2022-2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $2,258.03 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,495.05 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $1,321.19 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $902.60 | 2020-2025 | Glassia |
| Grifols USA, LLC | $409.07 | 2021-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $381.44 | 2019-2024 | Yupelri, Yupelri |
| Regeneron Healthcare Solutions, INC. | $237.28 | 2024-2025 | Dupixent |
| Verona Pharma, INC. | $233.44 | 2025 | Ohtuvayre |
| Baxter Healthcare | $231.07 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Genzyme Corporation | $222.16 | 2024-2025 | |
| Pulmonx Corporation | $205.50 | 2024-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Electromed, INC. | $199.42 | 2023-2025 | Smartvest |
| Insmed, INC. | $196.06 | 2023-2025 | Brinsupri, Arikayce |
| Boston Scientific Corporation | $168.16 | 2023 | Watchman Flx |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $160.08 | 2024-2025 | Acthar |
| Abiomed | $145.86 | 2019 | |
| Avinger INC. | $120.22 | 2019 | |
| Genentech USA, INC. | $118.54 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.86 | 2023 | |
| Advanced Respiratory, INC | $96.48 | 2021 | |
| Edwards Lifesciences Corporation | $84.46 | 2019 | |
| Fisher & Paykel Healthcare INC | $81.82 | 2019-2023 | Fisher & Paykel Healthcare |
| Viatris Specialty LLC | $81.36 | 2025 | Yupelri |
| Inogen, INC. | $79.82 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Harmony Biosciences LLC | $66.52 | 2025 | |
| Inspire Medical Systems, INC. | $45.22 | 2024 | Inspire |
| Abbott Laboratories | $29.96 | 2024 | Diamondback Coronary |
| Philips North America LLC | $22.69 | 2021 | |
| Resmed Corp | $17.60 | 2023 | |
| Body Vision Medical INC. | $14.62 | 2023 | Lungvision |
| Lilly USA, LLC | $14.43 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Balingit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.